Copyright Reports & Markets. All rights reserved.

Global and United States Drugs for Short Bowel Syndrome Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 GLP-2
    • 1.2.3 Growth Hormone
    • 1.2.4 Glutamine
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Drugs for Short Bowel Syndrome Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Drugs for Short Bowel Syndrome Market Perspective (2015-2026)
  • 2.2 Global Drugs for Short Bowel Syndrome Growth Trends by Regions
    • 2.2.1 Drugs for Short Bowel Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Drugs for Short Bowel Syndrome Historic Market Share by Regions (2015-2020)
    • 2.2.3 Drugs for Short Bowel Syndrome Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Drugs for Short Bowel Syndrome Players by Market Size
    • 3.1.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue (2015-2020)
    • 3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Players (2015-2020)
  • 3.2 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
  • 3.4 Global Drugs for Short Bowel Syndrome Market Concentration Ratio
    • 3.4.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2019
  • 3.5 Key Players Drugs for Short Bowel Syndrome Area Served
  • 3.6 Key Players Drugs for Short Bowel Syndrome Product Solution and Service
  • 3.7 Date of Enter into Drugs for Short Bowel Syndrome Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Short Bowel Syndrome Breakdown Data by Type (2015-2026)

  • 4.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Type (2015-2020)
  • 4.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2021-2026)

5 Drugs for Short Bowel Syndrome Breakdown Data by Application (2015-2026)

  • 5.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Application (2015-2020)
  • 5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Drugs for Short Bowel Syndrome Market Size (2015-2026)
  • 6.2 North America Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
  • 6.3 North America Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
  • 6.4 North America Drugs for Short Bowel Syndrome Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Drugs for Short Bowel Syndrome Market Size (2015-2026)
  • 7.2 Europe Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
  • 7.3 Europe Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
  • 7.4 Europe Drugs for Short Bowel Syndrome Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Drugs for Short Bowel Syndrome Market Size (2015-2026)
  • 8.2 China Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
  • 8.3 China Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
  • 8.4 China Drugs for Short Bowel Syndrome Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Drugs for Short Bowel Syndrome Market Size (2015-2026)
  • 9.2 Japan Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
  • 9.3 Japan Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
  • 9.4 Japan Drugs for Short Bowel Syndrome Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Drugs for Short Bowel Syndrome Market Size (2015-2026)
  • 10.2 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Ardelyx
    • 11.1.1 Ardelyx Company Details
    • 11.1.2 Ardelyx Business Overview
    • 11.1.3 Ardelyx Drugs for Short Bowel Syndrome Introduction
    • 11.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2015-2020))
    • 11.1.5 Ardelyx Recent Development
  • 11.2 Emmaus Life Sciences
    • 11.2.1 Emmaus Life Sciences Company Details
    • 11.2.2 Emmaus Life Sciences Business Overview
    • 11.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Introduction
    • 11.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.2.5 Emmaus Life Sciences Recent Development
  • 11.3 GLyPharma Therapeutic
    • 11.3.1 GLyPharma Therapeutic Company Details
    • 11.3.2 GLyPharma Therapeutic Business Overview
    • 11.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Introduction
    • 11.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.3.5 GLyPharma Therapeutic Recent Development
  • 11.4 Merck
    • 11.4.1 Merck Company Details
    • 11.4.2 Merck Business Overview
    • 11.4.3 Merck Drugs for Short Bowel Syndrome Introduction
    • 11.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.4.5 Merck Recent Development
  • 11.5 Naia Pharmaceuticals
    • 11.5.1 Naia Pharmaceuticals Company Details
    • 11.5.2 Naia Pharmaceuticals Business Overview
    • 11.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Introduction
    • 11.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.5.5 Naia Pharmaceuticals Recent Development
  • 11.6 Nutrinia
    • 11.6.1 Nutrinia Company Details
    • 11.6.2 Nutrinia Business Overview
    • 11.6.3 Nutrinia Drugs for Short Bowel Syndrome Introduction
    • 11.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.6.5 Nutrinia Recent Development
  • 11.7 OxThera
    • 11.7.1 OxThera Company Details
    • 11.7.2 OxThera Business Overview
    • 11.7.3 OxThera Drugs for Short Bowel Syndrome Introduction
    • 11.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.7.5 OxThera Recent Development
  • 11.8 Sancilio & Company
    • 11.8.1 Sancilio & Company Company Details
    • 11.8.2 Sancilio & Company Business Overview
    • 11.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Introduction
    • 11.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.8.5 Sancilio & Company Recent Development
  • 11.9 Takeda
    • 11.9.1 Takeda Company Details
    • 11.9.2 Takeda Business Overview
    • 11.9.3 Takeda Drugs for Short Bowel Syndrome Introduction
    • 11.9.4 Takeda Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.9.5 Takeda Recent Development
  • 11.10 Zealand Pharma
    • 11.10.1 Zealand Pharma Company Details
    • 11.10.2 Zealand Pharma Business Overview
    • 11.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Introduction
    • 11.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
    • 11.10.5 Zealand Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Drugs for Short Bowel Syndrome Scope and Market Size
    Drugs for Short Bowel Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Short Bowel Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    GLP-2
    Growth Hormone
    Glutamine
    Other

    Market segment by Application, split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    Based on regional and country-level analysis, the Drugs for Short Bowel Syndrome market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Drugs for Short Bowel Syndrome market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Ardelyx
    Emmaus Life Sciences
    GLyPharma Therapeutic
    Merck
    Naia Pharmaceuticals
    Nutrinia
    OxThera
    Sancilio & Company
    Takeda
    Zealand Pharma

    Buy now